Loading...
Combining Nelfinavir With Chloroquine Inhibits In Vivo Growth of Human Lung Cancer Xenograft Tumors
Background/Aim: Nelfinavir is a human immunodeficiency virus protease inhibitor that is currently being repositioned as an anticancer drug. Chloroquine, an anti-malarial lysosomotropic drug, inhibits autophagy. It has been reported that the combination of nelfinavir and chloroquine significantly enh...
Saved in:
| Published in: | In Vivo |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
International Institute of Anticancer Research
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7880743/ https://ncbi.nlm.nih.gov/pubmed/33402459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12241 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|